Table of Contents Author Guidelines Submit a Manuscript
International Journal of Chronic Diseases
Volume 2018, Article ID 1382705, 10 pages
https://doi.org/10.1155/2018/1382705
Research Article

Antihypertensive Medications and Change in Stages of Chronic Kidney Disease

1School of Public Health, Department of Epidemiology and Biostatistics, State University of New York Downstate Medical Center, Brooklyn, NY, USA
2College of Medicine, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, USA

Correspondence should be addressed to Marina Komaroff; moc.liamg@k2ramneg

Received 3 August 2017; Revised 19 January 2018; Accepted 28 January 2018; Published 25 February 2018

Academic Editor: Katarzyna Zorena

Copyright © 2018 Marina Komaroff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020. Washington, DC,” http://www.healthypeople.gov/2020/default.aspx.
  2. Kidney Disease Outcomes Quality Initiative (K/DOQI), “K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease,” Kidney Disease Outcomes Quality Initiative (K/DOQI), vol. 43, pp. S1–S290, 2004. View at Publisher · View at Google Scholar
  3. The National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)/ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIH Publication No. 14–4572 February 2014.
  4. Annals of Internal Medicine-In the Clinic® Chronic Kidney Disease American College of Physicians 2015.
  5. A. V. Chobanian, G. L. Bakris, H. R. Black et al., “The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report,” The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560–2572, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, pp. 1–150, 2013. View at Publisher · View at Google Scholar
  7. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES; National Institutes of Health National Heart, Lung, and Blood Institute National High Blood Pressure Education Program NIH Publication No. 04-5230; August 2004.
  8. T. H. Hostetter and M. Lising, “National kidney disease education program,” Journal of the American Society of Nephrology, vol. 94, 8, pp. 114S–116S, 2002. View at Publisher · View at Google Scholar
  9. T. F. Parker III, R. Blantz, T. Hostetter et al., “The Chronic Kidney Disease Initiative,” Journal of the American Society of Nephrology, vol. 15, no. 3, pp. 708–716, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Yoon, V. Burt, T. Louis, and M. D. Carroll, Hypertension among adults in the United States, 2009–2010. NCHS data brief, no 107, MD: National Center for Health Statistics, Hyattsville, Md, USA, 2012, http://www.cdc.gov/nchs/data/databriefs/db107.pdf.
  11. B. M. Egan, Y. Zhao, and R. N. Axon, “US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008,” The Journal of the American Medical Association, vol. 303, no. 20, pp. 2043–2050, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Nwankwo, S. S. S. Yoon, R. N. Vicki Burt, and Gu. Qiuping, Hypertension Among Adults in the United States: National Health and Nutrition Examination Survey, US Department of Health and Human Services, CDC/NCHS No.133, October 2013.
  13. K. L. Ong, A. W. K. Tso, K. S. L. Lam, and B. M. Y. Cheung, “Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension,” Hypertension, vol. 51, no. 4, pp. 1142–1148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. USRDS Annual Data Report; Volume1-Chronic Kidney Disease ;Volume2-End-Stage Renal Disease; 2014.
  15. L. A. Tomlinson, G. A. Abel, A. N. Chaudhry et al., “ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: A longitudinal ecological study,” PLoS ONE, vol. 8, no. 11, Article ID e78465, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. The SPRINT Research Group, “A randomized trial of intensive versus standard blood-pressure control,” The New England Journal of Medicine, vol. 373, no. 22, pp. 2103–2116, 2015, ClinicalTrials.gov number, NCT01206062. View at Publisher · View at Google Scholar
  17. National Center for Health Statistics, National Health and Nutrition Examination Survey (NHANES) manuals (1999-2000, 2001-2002, 2003-2004, 2005-2006, 2007-2008, 2009–2010, 2011–2012, and 2013-2014), 2013, http://www.cdc.gov/nchs/nhanes/nhanes.
  18. National Kidney Foundation, “K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification,” American Journal of Kidney Diseases, vol. 39, 1, pp. S1–S266, Feb 2002. View at Google Scholar
  19. M. T. Crim, S. S. Yoon, E. Ortiz et al., “National surveillance definitions for hypertension prevalence and control among adults,” Circulation: Cardiovascular Quality and Outcomes, vol. 5, no. 3, pp. 343–351, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. American Diabetes Association, “Standards of medical care in diabetes—2010,” Diabetes Care, vol. 33, supplement 1, pp. S11–S61, 2010. View at Publisher · View at Google Scholar
  21. Centers for Disease Control and Prevention, National Center for Health Statistics Division of Health and Nutrition Examination Surveys: National Health and Nutrition Examination Survey: Analytic Guidelines, 2013, http://www.cdc.gov/nchs /nhanes/.
  22. Q. Gu, V. L. Burt, C. F. Dillon, and S. Yoon, “Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the national health and nutrition examination survey, 2001 to 2010,” Circulation, vol. 126, no. 17, pp. 2105–2114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. D. C. Wheeler and G. J. Becker, “Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?” Kidney International, vol. 83, no. 3, pp. 377–383, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. National Institute for Health and Clinical Excellence, NICE clinical guidance. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. 2008.